Sonoma Pharmaceuticals, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated June 13, 2018, serves as a current report for Sonoma Pharmaceuticals, Inc. The filing announces the issuance of a press release and presentation regarding the Company's financial results for the fiscal quarter and fiscal year ended March 31, 2018.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the furnished exhibits (Exhibit 99.1 Press Release and Exhibit 99.2 Presentation) which are not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the body text. Investors must refer to the attached press release and presentation for comparative financial data.
Guidance, Outlook, and Risks
The report contains forward-looking statements regarding the Company's intentions, beliefs, expectations, and strategies. Management notes that these statements are based on current assumptions and are not guarantees of future performance. Actual results may differ materially due to risks and uncertainties discussed in the Company's Annual Report on Form 10-K. The Company does not undertake an obligation to update these statements except as required by law.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the quarter and year ended March 31, 2018.
- Examine Exhibit 99.2 (Presentation) for management's outlook and strategic updates.
- Consult the most recent Form 10-K for a comprehensive list of risk factors referenced in this filing.
- Verify the status of the Company's emerging growth company designation, as indicated by the unchecked box in the filing.